CDC investigating ‘large, ongoing’ outbreak of meningococcal disease in Florida
The Centers for Disease Control and Prevention (CDC) is investigating “one of the worst outbreaks of meningococcal disease among gay and bisexual men in U.S. […]
The Centers for Disease Control and Prevention (CDC) is investigating “one of the worst outbreaks of meningococcal disease among gay and bisexual men in U.S. […]
Women are more likely than males to experience long COVID after an infection, and are significantly more likely to experience complications in the nervous system […]
New Jersey detected its first probable monkeypox case, state health officials reported on Monday. The New Jersey Department of Health said in a news release […]
Shots: Obsidian to receive $75M in equity, up front, research milestones and is eligible to receive ~$1.3B as research, development, regulatory, and commercial milestones across […]
Shots: The enrollment of the first P-III study is currently underway & has reached 85% of its enrollment goal. In a P-II study of 336 […]
Shots: Schrödinger to receive $55M upfront and is eligible to receive $2.7B as preclinical, development, regulatory & commercial milestones along with royalties on sales of […]
The health system and biotech company are collaborating to create a Covid-19 patient registry biobank, which will combine de-identified patient data and AI technology to […]
Shots: The companies present the findings from a new exploratory sub-analysis of the P-III EMPEROR-Reduced study demonstrating that Jardiance (empagliflozin) reduced the risk of adverse […]
Shots: The US FDA has granted ODD for branaplam in HD. In preclinical trials, branaplam demonstrated a reduction in levels of the mutant huntingtin protein. […]
Shots: The companies will advance the prasinezumab into a P-IIb study in patients with early Parkinson’s disease based on positive signals of efficacy consistent with […]
Copyright © 2024 | WordPress Theme by MH Themes